The current institutional shareholding score of Stoke Therapeutics Inc is 10.00, ranking 1 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 118.29%, representing a quarter-over-quarter decrease of 3.39%. The largest institutional shareholder is John Hussman, holding a total of 87.12K shares, representing 0.13% of shares outstanding, with 3.63% decrease in holdings.